U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196124) titled 'BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma' on Sept. 19.
Brief Summary: This study is a single-arm, multicenter clinical trial of dose escalation and dose expansion.
Study Start Date: Oct. 10
Study Type: INTERVENTIONAL
Condition:
Multiple Myeloma Refractory
Intervention:
BIOLOGICAL: BCMA/GPRC5D CAR-T
A single infusion of BCMA/GPRC5D CAR-T Injection administered intravenously.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangzhou Bio-gene Technology Co., Ltd
Disclaimer: Curated by HT Syndication....